AI-generated analysis. Always verify with the original filing.
Sanuwave Health, Inc. announced record Q4 2025 revenues of $13.4 million (up 29.7% YoY) and full year 2025 revenues of $44.1 million (up 35.0% YoY), with Q4 GAAP operating income of $2.0 million and full year net income of $11.8 million. The company issued Q1 2026 revenue guidance of $9.6-10.3 million and full year 2026 guidance of $51.0-55.0 million.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act o
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated March 26, 2026 104 Cover Page Interactive Data File--the cover
| Metric | Value | Basis |
|---|---|---|
| Revenue | $44.10 | |
| Gross Margin % | 77.1% | GAAP |
| Operating Income | $4.90 | GAAP |
| Net Income | $11.80 | GAAP |
| Adjusted EBITDA | $13.60 | Non-GAAP |